Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, Jun 2026 and Jul 2026.
- Largest single sale: $2.7M (39,393 shares) of Ptc Therapeutics, Inc. on Apr 1, 2026. Filing
- Last sale before this period: Oct 3, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ptc Therapeutics, Inc. (PTCT) | Chief Technical Ops Officer | Jun 19, 2013 | Jul 13, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 9, 2026, Ptc Therapeutics, Inc.: sold 2,464 shares for $222K, under a disclosed plan; 2,464 shares acquired by exercising options. 1 filing: 1
- Jul 7, 2026, Ptc Therapeutics, Inc.: sold 24,613 shares for $2.2M, under a disclosed plan; 24,613 shares acquired by exercising options. 1 filing: 1
- Jul 6, 2026, Ptc Therapeutics, Inc.: sold 22,161 shares for $1.9M, under a disclosed plan; 22,161 shares acquired by exercising options. 1 filing: 1
- Jun 26, 2026, Ptc Therapeutics, Inc.: sold 8,130 shares for $693K, under a disclosed plan; 8,130 shares acquired by exercising options. 1 filing: 1
- Jun 25, 2026, Ptc Therapeutics, Inc.: sold 20,960 shares for $1.8M, under a disclosed plan; 20,960 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.